Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-04-26
2011-04-26
Andres, Janet L (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S311000
Reexamination Certificate
active
07932275
ABSTRACT:
The present invention is directed to 2-aminopyridine compounds which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of such diseases in which the beta-secretase enzyme is involved.
REFERENCES:
patent: 5540938 (1996-07-01), Masterson
patent: 6750232 (2004-06-01), Harada et al.
patent: 6951946 (2005-10-01), Kolb
patent: 2004/0006082 (2004-01-01), Harada et al.
patent: WO 03/106405 (2003-12-01), None
patent: WO2004/080376 (2004-09-01), None
patent: WO 2005/005374 (2005-01-01), None
patent: WO 2006/065204 (2006-06-01), None
Hagmann, et al., Bioorg & Med. Chem. Lett., 10 (2000); 1975-1978.
Coburn Craig A.
Holloway M. Katharine
Stachel Shawn J.
Andres Janet L
Devlin Gerard M.
MacMillan Keith D.
Merck Sharp & Dohme Corp.
Reese Heidi
LandOfFree
2-aminopyridine compounds useful as β-secretase... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-aminopyridine compounds useful as β-secretase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-aminopyridine compounds useful as β-secretase... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2660508